

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | parturition (GO:0007567) | 6.91570950 |
| 2 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 6.17655649 |
| 3 | daunorubicin metabolic process (GO:0044597) | 5.89686655 |
| 4 | polyketide metabolic process (GO:0030638) | 5.89686655 |
| 5 | doxorubicin metabolic process (GO:0044598) | 5.89686655 |
| 6 | membrane repolarization during action potential (GO:0086011) | 5.66622915 |
| 7 | behavioral response to nicotine (GO:0035095) | 5.59754389 |
| 8 | cell proliferation in forebrain (GO:0021846) | 5.21150302 |
| 9 | vocalization behavior (GO:0071625) | 4.92598201 |
| 10 | regulation of DNA endoreduplication (GO:0032875) | 4.64860474 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.46784470 |
| 12 | membrane repolarization (GO:0086009) | 4.33313232 |
| 13 | cellular potassium ion homeostasis (GO:0030007) | 4.24417462 |
| 14 | positive regulation of synapse maturation (GO:0090129) | 4.15438321 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.07463969 |
| 16 | regulation of membrane repolarization (GO:0060306) | 4.04439623 |
| 17 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.02035572 |
| 18 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.01719814 |
| 19 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.00889092 |
| 20 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.95042393 |
| 21 | retinal ganglion cell axon guidance (GO:0031290) | 3.93180036 |
| 22 | magnesium ion transport (GO:0015693) | 3.90169082 |
| 23 | viral transcription (GO:0019083) | 3.86981818 |
| 24 | neuron cell-cell adhesion (GO:0007158) | 3.86665591 |
| 25 | locomotory exploration behavior (GO:0035641) | 3.83177130 |
| 26 | regulation of skeletal muscle contraction (GO:0014819) | 3.75249754 |
| 27 | regulation of mesoderm development (GO:2000380) | 3.72201003 |
| 28 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.68599827 |
| 29 | negative regulation of response to food (GO:0032096) | 3.67935085 |
| 30 | negative regulation of appetite (GO:0032099) | 3.67935085 |
| 31 | translational termination (GO:0006415) | 3.66397981 |
| 32 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.62372532 |
| 33 | NADH dehydrogenase complex assembly (GO:0010257) | 3.62372532 |
| 34 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.62372532 |
| 35 | chaperone-mediated protein transport (GO:0072321) | 3.61852760 |
| 36 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.59378485 |
| 37 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.59229684 |
| 38 | protein complex biogenesis (GO:0070271) | 3.58267582 |
| 39 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.56655880 |
| 40 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.55862750 |
| 41 | regulation of synapse maturation (GO:0090128) | 3.54138082 |
| 42 | ATP synthesis coupled proton transport (GO:0015986) | 3.51596390 |
| 43 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.51596390 |
| 44 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.50802018 |
| 45 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.50802018 |
| 46 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.48810262 |
| 47 | proline transport (GO:0015824) | 3.45948919 |
| 48 | dendritic spine morphogenesis (GO:0060997) | 3.45288831 |
| 49 | neuron recognition (GO:0008038) | 3.43525053 |
| 50 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.40168995 |
| 51 | somite development (GO:0061053) | 3.36520574 |
| 52 | ribosomal small subunit biogenesis (GO:0042274) | 3.36014971 |
| 53 | regulation of potassium ion transmembrane transport (GO:1901379) | 3.32654520 |
| 54 | synaptic vesicle exocytosis (GO:0016079) | 3.31099179 |
| 55 | axonal fasciculation (GO:0007413) | 3.29466978 |
| 56 | protein neddylation (GO:0045116) | 3.27818495 |
| 57 | postsynaptic membrane organization (GO:0001941) | 3.26768170 |
| 58 | protein localization to synapse (GO:0035418) | 3.25396977 |
| 59 | exploration behavior (GO:0035640) | 3.25129407 |
| 60 | cellular response to electrical stimulus (GO:0071257) | 3.24694817 |
| 61 | glutamate receptor signaling pathway (GO:0007215) | 3.22391207 |
| 62 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.20406503 |
| 63 | protein polyglutamylation (GO:0018095) | 3.16171390 |
| 64 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.14021205 |
| 65 | auditory receptor cell stereocilium organization (GO:0060088) | 3.13916116 |
| 66 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.12315699 |
| 67 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.09799213 |
| 68 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.05735342 |
| 69 | chemical homeostasis within a tissue (GO:0048875) | 3.05091423 |
| 70 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.02289344 |
| 71 | surfactant homeostasis (GO:0043129) | 3.02279907 |
| 72 | synaptic vesicle maturation (GO:0016188) | 3.01232802 |
| 73 | sulfation (GO:0051923) | 3.00802388 |
| 74 | glutamate secretion (GO:0014047) | 2.99409951 |
| 75 | fat-soluble vitamin catabolic process (GO:0042363) | 2.99011503 |
| 76 | vitamin catabolic process (GO:0009111) | 2.99011503 |
| 77 | regulation of synaptic vesicle transport (GO:1902803) | 2.98589927 |
| 78 | regulation of glomerulus development (GO:0090192) | 2.98114819 |
| 79 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.98087835 |
| 80 | potassium ion import (GO:0010107) | 2.97476643 |
| 81 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.95759524 |
| 82 | neuron remodeling (GO:0016322) | 2.95753446 |
| 83 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.94501495 |
| 84 | cardiovascular system development (GO:0072358) | 2.93029387 |
| 85 | positive regulation of synapse assembly (GO:0051965) | 2.92620102 |
| 86 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.92252385 |
| 87 | layer formation in cerebral cortex (GO:0021819) | 2.91822489 |
| 88 | presynaptic membrane assembly (GO:0097105) | 2.91638555 |
| 89 | cotranslational protein targeting to membrane (GO:0006613) | 2.91114682 |
| 90 | synaptic transmission, glutamatergic (GO:0035249) | 2.90279608 |
| 91 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.89433170 |
| 92 | neuronal action potential propagation (GO:0019227) | 2.89417140 |
| 93 | neuron-neuron synaptic transmission (GO:0007270) | 2.88877829 |
| 94 | cellular anion homeostasis (GO:0030002) | 2.87720610 |
| 95 | nonmotile primary cilium assembly (GO:0035058) | 2.86688520 |
| 96 | protein targeting to ER (GO:0045047) | 2.86215152 |
| 97 | translational elongation (GO:0006414) | 2.84609041 |
| 98 | epithelial cilium movement (GO:0003351) | 2.84387460 |
| 99 | striatum development (GO:0021756) | 2.83644867 |
| 100 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.82896145 |
| 101 | inner ear receptor stereocilium organization (GO:0060122) | 2.82810628 |
| 102 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.82201743 |
| 103 | response to histamine (GO:0034776) | 2.81205346 |
| 104 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.80044184 |
| 105 | viral life cycle (GO:0019058) | 2.79939188 |
| 106 | multicellular organismal signaling (GO:0035637) | 2.79399420 |
| 107 | spinal cord development (GO:0021510) | 2.78755765 |
| 108 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.78732621 |
| 109 | regulation of postsynaptic membrane potential (GO:0060078) | 2.78672803 |
| 110 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.77520940 |
| 111 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.77478017 |
| 112 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.77301488 |
| 113 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.77141240 |
| 114 | regulation of synapse assembly (GO:0051963) | 2.75377788 |
| 115 | negative regulation of protein localization to cell surface (GO:2000009) | 2.74062499 |
| 116 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.73952616 |
| 117 | protein localization to endoplasmic reticulum (GO:0070972) | 2.73321746 |
| 118 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.71198085 |
| 119 | negative regulation of axon guidance (GO:1902668) | 2.70442516 |
| 120 | cellular protein complex disassembly (GO:0043624) | 2.69834870 |
| 121 | gamma-aminobutyric acid transport (GO:0015812) | 2.69776597 |
| 122 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.69734143 |
| 123 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.69528996 |
| 124 | neurotransmitter secretion (GO:0007269) | 2.68613093 |
| 125 | synapse assembly (GO:0007416) | 2.67577367 |
| 126 | dendritic spine organization (GO:0097061) | 2.67122942 |
| 127 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.67012322 |
| 128 | positive regulation of gastrulation (GO:2000543) | 2.66393096 |
| 129 | positive regulation of meiosis (GO:0045836) | 2.65834602 |
| 130 | positive regulation of neurotransmitter transport (GO:0051590) | 2.65431398 |
| 131 | positive regulation of neurological system process (GO:0031646) | 2.64232340 |
| 132 | dentate gyrus development (GO:0021542) | 2.64150555 |
| 133 | regulation of female receptivity (GO:0045924) | 2.63351278 |
| 134 | membrane hyperpolarization (GO:0060081) | 2.63053110 |
| 135 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.61321348 |
| 136 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.60781737 |
| 137 | flavonoid metabolic process (GO:0009812) | 2.60053072 |
| 138 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.59822059 |
| 139 | ovulation cycle (GO:0042698) | 2.59804220 |
| 140 | neuronal ion channel clustering (GO:0045161) | 2.58166495 |
| 141 | limb bud formation (GO:0060174) | 2.57441323 |
| 142 | regulation of cilium movement (GO:0003352) | 2.56652615 |
| 143 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.56561455 |
| 144 | response to electrical stimulus (GO:0051602) | 2.56514405 |
| 145 | membrane depolarization during action potential (GO:0086010) | 2.56326487 |
| 146 | synaptic vesicle endocytosis (GO:0048488) | 2.56277191 |
| 147 | innervation (GO:0060384) | 2.56161076 |
| 148 | membrane depolarization (GO:0051899) | 2.54987800 |
| 149 | cochlea development (GO:0090102) | 2.54890255 |
| 150 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.54737056 |
| 151 | cornea development in camera-type eye (GO:0061303) | 2.54703142 |
| 152 | long-term memory (GO:0007616) | 2.54519138 |
| 153 | regulation of synapse organization (GO:0050807) | 2.54310548 |
| 154 | behavioral fear response (GO:0001662) | 2.54238700 |
| 155 | behavioral defense response (GO:0002209) | 2.54238700 |
| 156 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.54103556 |
| 157 | establishment of nucleus localization (GO:0040023) | 2.54027888 |
| 158 | piRNA metabolic process (GO:0034587) | 2.52431187 |
| 159 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.51561664 |
| 160 | presynaptic membrane organization (GO:0097090) | 2.51460354 |
| 161 | potassium ion homeostasis (GO:0055075) | 2.50584074 |
| 162 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.50516680 |
| 163 | detection of calcium ion (GO:0005513) | 2.49761697 |
| 164 | glandular epithelial cell differentiation (GO:0002067) | 2.49760449 |
| 165 | response to pheromone (GO:0019236) | 2.49269390 |
| 166 | positive regulation of meiotic cell cycle (GO:0051446) | 2.48857077 |
| 167 | fear response (GO:0042596) | 2.48820224 |
| 168 | DNA deamination (GO:0045006) | 2.48578793 |
| 169 | serotonin metabolic process (GO:0042428) | 2.48396666 |
| 170 | transmission of nerve impulse (GO:0019226) | 2.48277407 |
| 171 | regulation of axon guidance (GO:1902667) | 2.48037037 |
| 172 | pharyngeal system development (GO:0060037) | 2.47778317 |
| 173 | mating behavior (GO:0007617) | 2.47744409 |
| 174 | regulation of neurotransmitter secretion (GO:0046928) | 2.46913449 |
| 175 | startle response (GO:0001964) | 2.46068304 |
| 176 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.45310770 |
| 177 | positive regulation of membrane potential (GO:0045838) | 2.44348936 |
| 178 | opioid receptor signaling pathway (GO:0038003) | 2.44341043 |
| 179 | regulation of synapse structural plasticity (GO:0051823) | 2.43726615 |
| 180 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.42649601 |
| 181 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.42619907 |
| 182 | activation of protein kinase A activity (GO:0034199) | 2.42418878 |
| 183 | synapse organization (GO:0050808) | 2.42025086 |
| 184 | glycine transport (GO:0015816) | 2.41474872 |
| 185 | long-term synaptic potentiation (GO:0060291) | 2.41309524 |
| 186 | negative regulation of amino acid transport (GO:0051956) | 2.39781120 |
| 187 | regulation of glutamate secretion (GO:0014048) | 2.36858520 |
| 188 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.36375030 |
| 189 | long term synaptic depression (GO:0060292) | 2.34904342 |
| 190 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.34774875 |
| 191 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.34327608 |
| 192 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.32995915 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.32242516 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.48249345 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.91551287 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.91413067 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.87275858 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.87103489 |
| 7 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.78436447 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.75728349 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.75728349 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.68622001 |
| 11 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.65275081 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.62489876 |
| 13 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.57483382 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54877872 |
| 15 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.53370372 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.52913022 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.48219912 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.45586944 |
| 19 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.29745232 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.23302140 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.18390986 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.10615553 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.03859349 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.01894596 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.99468703 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.97264764 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.88676321 |
| 28 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.88076935 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.87416707 |
| 30 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.81529743 |
| 31 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.81276020 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.80188734 |
| 33 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.78788220 |
| 34 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.78453223 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.77145351 |
| 36 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.70385048 |
| 37 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.68429983 |
| 38 | EWS_26573619_Chip-Seq_HEK293_Human | 1.67468195 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65290114 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.64537955 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.63844681 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.61404661 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.60112395 |
| 44 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59924230 |
| 45 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.51410668 |
| 46 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.50581334 |
| 47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.50053824 |
| 48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.49667291 |
| 49 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.48279412 |
| 50 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.46725256 |
| 51 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.43245179 |
| 52 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42923170 |
| 53 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.42181218 |
| 54 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.39441898 |
| 55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.36449215 |
| 56 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.36172640 |
| 57 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.35785161 |
| 58 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.35288203 |
| 59 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.34147072 |
| 60 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.33468566 |
| 61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33455939 |
| 62 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.32947044 |
| 63 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28357443 |
| 64 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.27451940 |
| 65 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27263110 |
| 66 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.25917848 |
| 67 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25597219 |
| 68 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.23405532 |
| 69 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.22506351 |
| 70 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.22141820 |
| 71 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.21368308 |
| 72 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.21063997 |
| 73 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20795247 |
| 74 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.20641796 |
| 75 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.20094528 |
| 76 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.19314898 |
| 77 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19021469 |
| 78 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18244789 |
| 79 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18120201 |
| 80 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.17892047 |
| 81 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16706348 |
| 82 | FUS_26573619_Chip-Seq_HEK293_Human | 1.16480784 |
| 83 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.16029918 |
| 84 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.15890169 |
| 85 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15784468 |
| 86 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.15389374 |
| 87 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.14709530 |
| 88 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13790397 |
| 89 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.13760523 |
| 90 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13118321 |
| 91 | TP53_16413492_ChIP-PET_HCT116_Human | 1.12089126 |
| 92 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.11251342 |
| 93 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10535997 |
| 94 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.10369348 |
| 95 | AR_19668381_ChIP-Seq_PC3_Human | 1.09071373 |
| 96 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08962843 |
| 97 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.08665047 |
| 98 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08481387 |
| 99 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.08400053 |
| 100 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08400053 |
| 101 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07977046 |
| 102 | NCOR_22424771_ChIP-Seq_293T_Human | 1.07383325 |
| 103 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07099794 |
| 104 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04793707 |
| 105 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04793707 |
| 106 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.04292074 |
| 107 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.04165557 |
| 108 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04066458 |
| 109 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03244362 |
| 110 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.02609546 |
| 111 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.02574885 |
| 112 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.01831362 |
| 113 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01607779 |
| 114 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.00449753 |
| 115 | JUN_21703547_ChIP-Seq_K562_Human | 1.00363362 |
| 116 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99648179 |
| 117 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97970545 |
| 118 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.97963739 |
| 119 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97504248 |
| 120 | VDR_22108803_ChIP-Seq_LS180_Human | 0.97495379 |
| 121 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.97241711 |
| 122 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96817485 |
| 123 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.96277880 |
| 124 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.96277880 |
| 125 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.95424424 |
| 126 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95388129 |
| 127 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94127344 |
| 128 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93938585 |
| 129 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93045795 |
| 130 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.90120460 |
| 131 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.90106883 |
| 132 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90095732 |
| 133 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.89822855 |
| 134 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.89434904 |
| 135 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89411960 |
| 136 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.89130510 |
| 137 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.88858802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.21816204 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.75601476 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 2.84628402 |
| 4 | MP0006276_abnormal_autonomic_nervous | 2.70036999 |
| 5 | MP0008004_abnormal_stomach_pH | 2.54749692 |
| 6 | MP0008877_abnormal_DNA_methylation | 2.54547352 |
| 7 | MP0005423_abnormal_somatic_nervous | 2.51999271 |
| 8 | MP0005645_abnormal_hypothalamus_physiol | 2.49377432 |
| 9 | MP0003122_maternal_imprinting | 2.48888949 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.44116466 |
| 11 | MP0009745_abnormal_behavioral_response | 2.43710534 |
| 12 | MP0003123_paternal_imprinting | 2.39499978 |
| 13 | MP0009046_muscle_twitch | 2.35175883 |
| 14 | MP0001486_abnormal_startle_reflex | 2.32740404 |
| 15 | MP0002063_abnormal_learning/memory/cond | 2.23655479 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.20635416 |
| 17 | MP0002064_seizures | 2.14357122 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.09585444 |
| 19 | MP0002160_abnormal_reproductive_system | 2.06361391 |
| 20 | MP0005377_hearing/vestibular/ear_phenot | 2.02439862 |
| 21 | MP0003878_abnormal_ear_physiology | 2.02439862 |
| 22 | MP0001440_abnormal_grooming_behavior | 1.96627837 |
| 23 | MP0003646_muscle_fatigue | 1.92381509 |
| 24 | MP0002272_abnormal_nervous_system | 1.89648060 |
| 25 | MP0009379_abnormal_foot_pigmentation | 1.87181655 |
| 26 | MP0002735_abnormal_chemical_nociception | 1.85454452 |
| 27 | MP0000566_synostosis | 1.84834121 |
| 28 | MP0002734_abnormal_mechanical_nocicepti | 1.84661719 |
| 29 | MP0000049_abnormal_middle_ear | 1.84040585 |
| 30 | MP0004270_analgesia | 1.77145201 |
| 31 | MP0003879_abnormal_hair_cell | 1.76377137 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 1.69740486 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.68523637 |
| 34 | MP0002184_abnormal_innervation | 1.67547011 |
| 35 | MP0002736_abnormal_nociception_after | 1.63454738 |
| 36 | MP0004130_abnormal_muscle_cell | 1.63006604 |
| 37 | MP0002102_abnormal_ear_morphology | 1.60750565 |
| 38 | MP0002067_abnormal_sensory_capabilities | 1.60308727 |
| 39 | MP0005389_reproductive_system_phenotype | 1.59839943 |
| 40 | MP0005551_abnormal_eye_electrophysiolog | 1.58208176 |
| 41 | MP0000778_abnormal_nervous_system | 1.56759916 |
| 42 | MP0002733_abnormal_thermal_nociception | 1.55930506 |
| 43 | MP0008789_abnormal_olfactory_epithelium | 1.55390811 |
| 44 | MP0004858_abnormal_nervous_system | 1.53070406 |
| 45 | MP0004133_heterotaxia | 1.51894206 |
| 46 | MP0002653_abnormal_ependyma_morphology | 1.50222578 |
| 47 | MP0003938_abnormal_ear_development | 1.50218127 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.49069082 |
| 49 | MP0001970_abnormal_pain_threshold | 1.45966901 |
| 50 | MP0006072_abnormal_retinal_apoptosis | 1.45450523 |
| 51 | MP0004742_abnormal_vestibular_system | 1.44768221 |
| 52 | MP0002163_abnormal_gland_morphology | 1.44167813 |
| 53 | MP0004924_abnormal_behavior | 1.41960693 |
| 54 | MP0005386_behavior/neurological_phenoty | 1.41960693 |
| 55 | MP0004272_abnormal_basement_membrane | 1.38268168 |
| 56 | MP0004142_abnormal_muscle_tone | 1.37869079 |
| 57 | MP0004782_abnormal_surfactant_physiolog | 1.37575544 |
| 58 | MP0001177_atelectasis | 1.37394017 |
| 59 | MP0003011_delayed_dark_adaptation | 1.34157557 |
| 60 | MP0003942_abnormal_urinary_system | 1.29105123 |
| 61 | MP0000751_myopathy | 1.27930225 |
| 62 | MP0009780_abnormal_chondrocyte_physiolo | 1.27870680 |
| 63 | MP0001529_abnormal_vocalization | 1.19534847 |
| 64 | MP0002752_abnormal_somatic_nervous | 1.19331663 |
| 65 | MP0001188_hyperpigmentation | 1.16084898 |
| 66 | MP0005503_abnormal_tendon_morphology | 1.14463722 |
| 67 | MP0005195_abnormal_posterior_eye | 1.12253339 |
| 68 | MP0001502_abnormal_circadian_rhythm | 1.11560984 |
| 69 | MP0004085_abnormal_heartbeat | 1.10360060 |
| 70 | MP0001984_abnormal_olfaction | 1.09612761 |
| 71 | MP0009053_abnormal_anal_canal | 1.09607917 |
| 72 | MP0001986_abnormal_taste_sensitivity | 1.08120434 |
| 73 | MP0000569_abnormal_digit_pigmentation | 1.07217328 |
| 74 | MP0005394_taste/olfaction_phenotype | 1.05939194 |
| 75 | MP0005499_abnormal_olfactory_system | 1.05939194 |
| 76 | MP0010386_abnormal_urinary_bladder | 1.04968947 |
| 77 | MP0003385_abnormal_body_wall | 1.04487842 |
| 78 | MP0008995_early_reproductive_senescence | 1.02687446 |
| 79 | MP0003941_abnormal_skin_development | 1.02518478 |
| 80 | MP0002138_abnormal_hepatobiliary_system | 1.02376642 |
| 81 | MP0003787_abnormal_imprinting | 1.01773655 |
| 82 | MP0001919_abnormal_reproductive_system | 1.01645706 |
| 83 | MP0004215_abnormal_myocardial_fiber | 1.00728946 |
| 84 | MP0002909_abnormal_adrenal_gland | 1.00381736 |
| 85 | MP0004019_abnormal_vitamin_homeostasis | 0.99874366 |
| 86 | MP0000631_abnormal_neuroendocrine_gland | 0.99625506 |
| 87 | MP0002928_abnormal_bile_duct | 0.99231636 |
| 88 | MP0008872_abnormal_physiological_respon | 0.99091139 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 0.98205698 |
| 90 | MP0001485_abnormal_pinna_reflex | 0.98169110 |
| 91 | MP0001293_anophthalmia | 0.98060620 |
| 92 | MP0004484_altered_response_of | 0.98043374 |
| 93 | MP0002066_abnormal_motor_capabilities/c | 0.96436522 |
| 94 | MP0003121_genomic_imprinting | 0.95997427 |
| 95 | MP0002882_abnormal_neuron_morphology | 0.95686924 |
| 96 | MP0005171_absent_coat_pigmentation | 0.95479304 |
| 97 | MP0002938_white_spotting | 0.95023960 |
| 98 | MP0001958_emphysema | 0.94606804 |
| 99 | MP0000537_abnormal_urethra_morphology | 0.94595940 |
| 100 | MP0004811_abnormal_neuron_physiology | 0.94462459 |
| 101 | MP0001664_abnormal_digestion | 0.94062684 |
| 102 | MP0000678_abnormal_parathyroid_gland | 0.92575563 |
| 103 | MP0003119_abnormal_digestive_system | 0.91766283 |
| 104 | MP0001346_abnormal_lacrimal_gland | 0.91058102 |
| 105 | MP0005670_abnormal_white_adipose | 0.90791842 |
| 106 | MP0010368_abnormal_lymphatic_system | 0.90643672 |
| 107 | MP0008569_lethality_at_weaning | 0.90283503 |
| 108 | MP0006138_congestive_heart_failure | 0.89192298 |
| 109 | MP0005367_renal/urinary_system_phenotyp | 0.88469900 |
| 110 | MP0000516_abnormal_urinary_system | 0.88469900 |
| 111 | MP0003136_yellow_coat_color | 0.87584020 |
| 112 | MP0000534_abnormal_ureter_morphology | 0.86537149 |
| 113 | MP0004134_abnormal_chest_morphology | 0.85488501 |
| 114 | MP0005253_abnormal_eye_physiology | 0.85461518 |
| 115 | MP0000955_abnormal_spinal_cord | 0.85446676 |
| 116 | MP0008775_abnormal_heart_ventricle | 0.85266041 |
| 117 | MP0003937_abnormal_limbs/digits/tail_de | 0.84947053 |
| 118 | MP0001905_abnormal_dopamine_level | 0.83030927 |
| 119 | MP0000681_abnormal_thyroid_gland | 0.82408533 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.82390567 |
| 121 | MP0003890_abnormal_embryonic-extraembry | 0.82022849 |
| 122 | MP0005623_abnormal_meninges_morphology | 0.81852718 |
| 123 | MP0008875_abnormal_xenobiotic_pharmacok | 0.81421584 |
| 124 | MP0003045_fibrosis | 0.81091334 |
| 125 | MP0006292_abnormal_olfactory_placode | 0.80682347 |
| 126 | MP0001879_abnormal_lymphatic_vessel | 0.80532461 |
| 127 | MP0001963_abnormal_hearing_physiology | 0.80301579 |
| 128 | MP0009250_abnormal_appendicular_skeleto | 0.79764958 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.79567937 |
| 130 | MP0005084_abnormal_gallbladder_morpholo | 0.79547625 |
| 131 | MP0002638_abnormal_pupillary_reflex | 0.77990467 |
| 132 | MP0002822_catalepsy | 0.76504260 |
| 133 | MP0003283_abnormal_digestive_organ | 0.75657008 |
| 134 | MP0000026_abnormal_inner_ear | 0.75284309 |
| 135 | MP0002152_abnormal_brain_morphology | 0.75006421 |
| 136 | MP0005388_respiratory_system_phenotype | 0.74732550 |
| 137 | MP0002133_abnormal_respiratory_system | 0.74732550 |
| 138 | MP0004084_abnormal_cardiac_muscle | 0.74642377 |
| 139 | MP0001943_abnormal_respiration | 0.74340056 |
| 140 | MP0002249_abnormal_larynx_morphology | 0.74284766 |
| 141 | MP0004885_abnormal_endolymph | 0.73422301 |
| 142 | MP0002876_abnormal_thyroid_physiology | 0.72021238 |
| 143 | MP0005248_abnormal_Harderian_gland | 0.70486544 |
| 144 | MP0001299_abnormal_eye_distance/ | 0.69882116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.71443569 |
| 2 | Focal seizures (HP:0007359) | 4.23449434 |
| 3 | Stenosis of the external auditory canal (HP:0000402) | 4.02441315 |
| 4 | Febrile seizures (HP:0002373) | 3.82005234 |
| 5 | Absent eyebrow (HP:0002223) | 3.80755862 |
| 6 | Nephronophthisis (HP:0000090) | 3.74278110 |
| 7 | Parakeratosis (HP:0001036) | 3.64418785 |
| 8 | Ulnar claw (HP:0001178) | 3.52683929 |
| 9 | Follicular hyperkeratosis (HP:0007502) | 3.43625369 |
| 10 | Abnormality of midbrain morphology (HP:0002418) | 3.41251483 |
| 11 | Molar tooth sign on MRI (HP:0002419) | 3.41251483 |
| 12 | Atonic seizures (HP:0010819) | 3.37746952 |
| 13 | Pancreatic cysts (HP:0001737) | 3.33957527 |
| 14 | Septo-optic dysplasia (HP:0100842) | 3.32228056 |
| 15 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.29696034 |
| 16 | Absent/shortened dynein arms (HP:0200106) | 3.29696034 |
| 17 | Epileptic encephalopathy (HP:0200134) | 3.26218623 |
| 18 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.25345209 |
| 19 | True hermaphroditism (HP:0010459) | 3.23240412 |
| 20 | Action tremor (HP:0002345) | 3.18647271 |
| 21 | Pancreatic fibrosis (HP:0100732) | 3.13085071 |
| 22 | Osteomalacia (HP:0002749) | 3.12574841 |
| 23 | Abnormality of the renal medulla (HP:0100957) | 3.09101154 |
| 24 | Unilateral renal agenesis (HP:0000122) | 3.07548343 |
| 25 | Myokymia (HP:0002411) | 3.01983238 |
| 26 | Progressive cerebellar ataxia (HP:0002073) | 2.91022311 |
| 27 | Congenital, generalized hypertrichosis (HP:0004540) | 2.87534130 |
| 28 | Abolished electroretinogram (ERG) (HP:0000550) | 2.83435413 |
| 29 | Asplenia (HP:0001746) | 2.81642965 |
| 30 | Absence seizures (HP:0002121) | 2.80014415 |
| 31 | Absent eyelashes (HP:0000561) | 2.79873929 |
| 32 | Visual hallucinations (HP:0002367) | 2.79574307 |
| 33 | Hyperventilation (HP:0002883) | 2.75214585 |
| 34 | Oligodontia (HP:0000677) | 2.75061586 |
| 35 | Abnormal number of erythroid precursors (HP:0012131) | 2.72550328 |
| 36 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.71967870 |
| 37 | Broad-based gait (HP:0002136) | 2.67166537 |
| 38 | Insidious onset (HP:0003587) | 2.59788916 |
| 39 | Termporal pattern (HP:0011008) | 2.59788916 |
| 40 | Medial flaring of the eyebrow (HP:0010747) | 2.55905754 |
| 41 | Decreased circulating renin level (HP:0003351) | 2.55614990 |
| 42 | Short femoral neck (HP:0100864) | 2.54413116 |
| 43 | Acute necrotizing encephalopathy (HP:0006965) | 2.54217963 |
| 44 | Alopecia of scalp (HP:0002293) | 2.53950650 |
| 45 | Dialeptic seizures (HP:0011146) | 2.51279690 |
| 46 | Adrenal hypoplasia (HP:0000835) | 2.51229805 |
| 47 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.49112944 |
| 48 | Abnormal ciliary motility (HP:0012262) | 2.49081081 |
| 49 | Male pseudohermaphroditism (HP:0000037) | 2.46922656 |
| 50 | Generalized tonic-clonic seizures (HP:0002069) | 2.45218184 |
| 51 | Methylmalonic acidemia (HP:0002912) | 2.40132926 |
| 52 | Limb dystonia (HP:0002451) | 2.38098962 |
| 53 | Preauricular pit (HP:0004467) | 2.35726426 |
| 54 | Periauricular skin pits (HP:0100277) | 2.35726426 |
| 55 | Hypoplastic pelvis (HP:0008839) | 2.34741707 |
| 56 | Congenital stationary night blindness (HP:0007642) | 2.33797192 |
| 57 | Narrow nasal bridge (HP:0000446) | 2.33175638 |
| 58 | Small hand (HP:0200055) | 2.32129389 |
| 59 | Tubular atrophy (HP:0000092) | 2.28505309 |
| 60 | Cutaneous finger syndactyly (HP:0010554) | 2.27596898 |
| 61 | Optic nerve hypoplasia (HP:0000609) | 2.27084298 |
| 62 | Pendular nystagmus (HP:0012043) | 2.26499538 |
| 63 | Abnormality of the frontal sinuses (HP:0002687) | 2.26192862 |
| 64 | Abnormality of the renal collecting system (HP:0004742) | 2.25626782 |
| 65 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.24961000 |
| 66 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.24784171 |
| 67 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.24360158 |
| 68 | Hyperglycinemia (HP:0002154) | 2.24359042 |
| 69 | Abnormality of the renal cortex (HP:0011035) | 2.23789443 |
| 70 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.22366330 |
| 71 | Agitation (HP:0000713) | 2.21373957 |
| 72 | Midline defect of the nose (HP:0004122) | 2.19768965 |
| 73 | 3-Methylglutaconic aciduria (HP:0003535) | 2.19545745 |
| 74 | Mitochondrial inheritance (HP:0001427) | 2.18725387 |
| 75 | Abnormality of renal resorption (HP:0011038) | 2.18681784 |
| 76 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.18664300 |
| 77 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.17515959 |
| 78 | Gait imbalance (HP:0002141) | 2.15968860 |
| 79 | Drooling (HP:0002307) | 2.15777032 |
| 80 | Excessive salivation (HP:0003781) | 2.15777032 |
| 81 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.15119720 |
| 82 | Recurrent corneal erosions (HP:0000495) | 2.14951062 |
| 83 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.13500536 |
| 84 | Absent speech (HP:0001344) | 2.13372798 |
| 85 | Acute encephalopathy (HP:0006846) | 2.13324604 |
| 86 | Rib fusion (HP:0000902) | 2.11774716 |
| 87 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.09144587 |
| 88 | Hyperphosphatemia (HP:0002905) | 2.08962990 |
| 89 | Progressive macrocephaly (HP:0004481) | 2.08806108 |
| 90 | Syncope (HP:0001279) | 2.08145133 |
| 91 | Prolonged QT interval (HP:0001657) | 2.08019580 |
| 92 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.07956105 |
| 93 | Hypoventilation (HP:0002791) | 2.06227494 |
| 94 | Amblyopia (HP:0000646) | 2.05523742 |
| 95 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.05210561 |
| 96 | Abnormality of dental color (HP:0011073) | 2.03936774 |
| 97 | Cystic liver disease (HP:0006706) | 2.03850292 |
| 98 | Exotropia (HP:0000577) | 2.03342865 |
| 99 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.02721762 |
| 100 | Short 4th metacarpal (HP:0010044) | 2.02721762 |
| 101 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.02378202 |
| 102 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.02290075 |
| 103 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.02290075 |
| 104 | Congenital primary aphakia (HP:0007707) | 2.00237866 |
| 105 | Sclerocornea (HP:0000647) | 2.00142273 |
| 106 | Anomalous pulmonary venous return (HP:0010772) | 2.00140370 |
| 107 | Persistence of primary teeth (HP:0006335) | 2.00130549 |
| 108 | Abnormality of cochlea (HP:0000375) | 1.99829131 |
| 109 | Thyroid-stimulating hormone excess (HP:0002925) | 1.98983485 |
| 110 | Broad metatarsal (HP:0001783) | 1.98518726 |
| 111 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.98009090 |
| 112 | Maternal diabetes (HP:0009800) | 1.97968412 |
| 113 | Hypoplasia of the ulna (HP:0003022) | 1.97391490 |
| 114 | Primary atrial arrhythmia (HP:0001692) | 1.95811585 |
| 115 | Vaginal atresia (HP:0000148) | 1.95458178 |
| 116 | Widely spaced teeth (HP:0000687) | 1.95226586 |
| 117 | Aplasia cutis congenita (HP:0001057) | 1.92885580 |
| 118 | Abnormal pancreas size (HP:0012094) | 1.92379723 |
| 119 | Genital tract atresia (HP:0001827) | 1.90906865 |
| 120 | Cutaneous syndactyly (HP:0012725) | 1.90860401 |
| 121 | Atrial fibrillation (HP:0005110) | 1.90606715 |
| 122 | Short tibia (HP:0005736) | 1.88947658 |
| 123 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.88036473 |
| 124 | Increased CSF lactate (HP:0002490) | 1.87871108 |
| 125 | Supranuclear gaze palsy (HP:0000605) | 1.87838979 |
| 126 | Specific learning disability (HP:0001328) | 1.87498844 |
| 127 | Abnormal eating behavior (HP:0100738) | 1.87426674 |
| 128 | Absent septum pellucidum (HP:0001331) | 1.87422017 |
| 129 | Abnormality of DNA repair (HP:0003254) | 1.86320575 |
| 130 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.86200032 |
| 131 | Nephrogenic diabetes insipidus (HP:0009806) | 1.86102236 |
| 132 | Poor eye contact (HP:0000817) | 1.85934883 |
| 133 | Renal dysplasia (HP:0000110) | 1.85796256 |
| 134 | Abnormal EKG (HP:0003115) | 1.84983768 |
| 135 | Type II lissencephaly (HP:0007260) | 1.84795829 |
| 136 | Pallor (HP:0000980) | 1.84575425 |
| 137 | Furrowed tongue (HP:0000221) | 1.84511369 |
| 138 | Abnormality of the lacrimal duct (HP:0011481) | 1.84497968 |
| 139 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.83441653 |
| 140 | Short 1st metacarpal (HP:0010034) | 1.83322218 |
| 141 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.83322218 |
| 142 | Genetic anticipation (HP:0003743) | 1.83316949 |
| 143 | Metabolic alkalosis (HP:0200114) | 1.83074961 |
| 144 | Goiter (HP:0000853) | 1.82837493 |
| 145 | Fibular aplasia (HP:0002990) | 1.82668827 |
| 146 | Steppage gait (HP:0003376) | 1.81502789 |
| 147 | Lip pit (HP:0100267) | 1.81416451 |
| 148 | Tubulointerstitial fibrosis (HP:0005576) | 1.80640260 |
| 149 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.80290690 |
| 150 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.79569286 |
| 151 | Short hallux (HP:0010109) | 1.79495634 |
| 152 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.79254090 |
| 153 | Macrocytic anemia (HP:0001972) | 1.79063713 |
| 154 | Paralysis (HP:0003470) | 1.78082459 |
| 155 | Hyperalaninemia (HP:0003348) | 1.78008054 |
| 156 | Supraventricular arrhythmia (HP:0005115) | 1.77547937 |
| 157 | Absent hair (HP:0002298) | 1.77436154 |
| 158 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.76289794 |
| 159 | Aplasia of the phalanges of the hand (HP:0009802) | 1.76289794 |
| 160 | Aplasia involving bones of the extremities (HP:0009825) | 1.76289794 |
| 161 | Supraventricular tachycardia (HP:0004755) | 1.75959277 |
| 162 | Fetal akinesia sequence (HP:0001989) | 1.75820562 |
| 163 | Abnormality of the nasolacrimal system (HP:0000614) | 1.75376696 |
| 164 | Abnormality of incisor morphology (HP:0011063) | 1.74821463 |
| 165 | Gaze-evoked nystagmus (HP:0000640) | 1.73335662 |
| 166 | Polyphagia (HP:0002591) | 1.73179460 |
| 167 | Protruding tongue (HP:0010808) | 1.72055188 |
| 168 | Morphological abnormality of the middle ear (HP:0008609) | 1.71499751 |
| 169 | Nasolacrimal duct obstruction (HP:0000579) | 1.71192773 |
| 170 | Hyperthyroidism (HP:0000836) | 1.71049199 |
| 171 | Abnormality of the right ventricle (HP:0001707) | 1.70956664 |
| 172 | Postural tremor (HP:0002174) | 1.70860053 |
| 173 | Hyperactive renin-angiotensin system (HP:0000841) | 1.70014772 |
| 174 | Intellectual disability, moderate (HP:0002342) | 1.69034587 |
| 175 | Anxiety (HP:0000739) | 1.65456186 |
| 176 | Sudden death (HP:0001699) | 1.64721426 |
| 177 | Ventricular fibrillation (HP:0001663) | 1.60626433 |
| 178 | Impaired social interactions (HP:0000735) | 1.60619474 |
| 179 | Abnormal social behavior (HP:0012433) | 1.60619474 |
| 180 | Truncal ataxia (HP:0002078) | 1.60418994 |
| 181 | Abnormality of salivation (HP:0100755) | 1.60005779 |
| 182 | Stereotypic behavior (HP:0000733) | 1.56994192 |
| 183 | Hemiparesis (HP:0001269) | 1.55161141 |
| 184 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.54480447 |
| 185 | Cerebral inclusion bodies (HP:0100314) | 1.51878928 |
| 186 | Incomplete penetrance (HP:0003829) | 1.51432716 |
| 187 | Vertebral arch anomaly (HP:0008438) | 1.51303697 |
| 188 | Chronic hepatic failure (HP:0100626) | 1.51177433 |
| 189 | Abnormality of the parietal bone (HP:0002696) | 1.50761269 |
| 190 | Progressive inability to walk (HP:0002505) | 1.50272354 |
| 191 | Neurofibrillary tangles (HP:0002185) | 1.48432319 |
| 192 | Coronal craniosynostosis (HP:0004440) | 1.46421925 |
| 193 | Inability to walk (HP:0002540) | 1.45954163 |
| 194 | Hyperkalemia (HP:0002153) | 1.45598838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.95627782 |
| 2 | SIK3 | 3.94772274 |
| 3 | STK16 | 3.59104365 |
| 4 | SIK2 | 3.27219745 |
| 5 | FRK | 3.26875295 |
| 6 | MAP3K4 | 3.16284905 |
| 7 | EPHA4 | 3.05755083 |
| 8 | MAP2K7 | 2.77269394 |
| 9 | TLK1 | 2.72104759 |
| 10 | CASK | 2.48761171 |
| 11 | TAOK3 | 2.39025573 |
| 12 | MARK1 | 2.38120222 |
| 13 | WNK4 | 2.35125254 |
| 14 | MAP3K12 | 2.27174212 |
| 15 | GRK1 | 2.26024809 |
| 16 | SIK1 | 2.12425503 |
| 17 | MAP3K9 | 2.01041693 |
| 18 | MAP2K4 | 1.95042457 |
| 19 | NTRK2 | 1.88192354 |
| 20 | DYRK2 | 1.85584921 |
| 21 | DAPK2 | 1.83953235 |
| 22 | MAPK13 | 1.83440905 |
| 23 | BCKDK | 1.77993593 |
| 24 | PINK1 | 1.77238610 |
| 25 | LATS2 | 1.75487941 |
| 26 | ARAF | 1.72354549 |
| 27 | ACVR1B | 1.70621708 |
| 28 | NUAK1 | 1.68799826 |
| 29 | MINK1 | 1.64681345 |
| 30 | RPS6KA6 | 1.58585173 |
| 31 | RPS6KA2 | 1.56728729 |
| 32 | MUSK | 1.53668169 |
| 33 | EPHB2 | 1.52555124 |
| 34 | PLK2 | 1.47270606 |
| 35 | PAK6 | 1.46928338 |
| 36 | BRAF | 1.45713279 |
| 37 | CAMK1G | 1.45612670 |
| 38 | TNIK | 1.43994099 |
| 39 | STK39 | 1.43467708 |
| 40 | LATS1 | 1.42769666 |
| 41 | RIPK4 | 1.42053855 |
| 42 | RPS6KC1 | 1.36202852 |
| 43 | RPS6KL1 | 1.36202852 |
| 44 | TIE1 | 1.35886605 |
| 45 | PNCK | 1.35600126 |
| 46 | FGFR2 | 1.34689437 |
| 47 | WNK3 | 1.31973029 |
| 48 | GRK5 | 1.30669774 |
| 49 | FER | 1.25970532 |
| 50 | STK38 | 1.24794903 |
| 51 | ZAK | 1.20607608 |
| 52 | KSR1 | 1.18239242 |
| 53 | PLK4 | 1.13399343 |
| 54 | MARK2 | 1.11340553 |
| 55 | PRPF4B | 1.11190294 |
| 56 | NTRK1 | 1.08226672 |
| 57 | AKT3 | 1.05853128 |
| 58 | CAMK1 | 1.03026100 |
| 59 | CDK5 | 1.02996048 |
| 60 | GRK7 | 1.00701098 |
| 61 | CAMK1D | 0.98169607 |
| 62 | SGK2 | 0.96641771 |
| 63 | PTK2B | 0.95765503 |
| 64 | UHMK1 | 0.95555437 |
| 65 | CAMK2A | 0.93469616 |
| 66 | CDC7 | 0.93161185 |
| 67 | PHKG1 | 0.92815153 |
| 68 | PHKG2 | 0.92815153 |
| 69 | PIM2 | 0.89647691 |
| 70 | ADRBK2 | 0.89143087 |
| 71 | DYRK3 | 0.85649004 |
| 72 | PAK3 | 0.85065250 |
| 73 | ABL2 | 0.85023145 |
| 74 | CDK8 | 0.83653206 |
| 75 | OXSR1 | 0.81848174 |
| 76 | PIK3CA | 0.81704648 |
| 77 | WNK1 | 0.81671077 |
| 78 | PRKCI | 0.78047409 |
| 79 | LMTK2 | 0.77527447 |
| 80 | AURKA | 0.77204044 |
| 81 | SGK223 | 0.76328849 |
| 82 | SGK494 | 0.76328849 |
| 83 | STK24 | 0.75889117 |
| 84 | PRKD3 | 0.75435550 |
| 85 | MAPK15 | 0.75179964 |
| 86 | DAPK1 | 0.74932514 |
| 87 | RET | 0.74255821 |
| 88 | PRKCE | 0.73320778 |
| 89 | MAP3K2 | 0.72716604 |
| 90 | INSRR | 0.71867673 |
| 91 | STK38L | 0.70954693 |
| 92 | DMPK | 0.70454573 |
| 93 | PKN1 | 0.69028198 |
| 94 | TXK | 0.68028352 |
| 95 | PRKCG | 0.67446307 |
| 96 | SGK1 | 0.63794059 |
| 97 | PIM1 | 0.62945249 |
| 98 | BMPR1B | 0.62594133 |
| 99 | MAP4K2 | 0.62580162 |
| 100 | MAP3K6 | 0.62297163 |
| 101 | ERBB3 | 0.62168759 |
| 102 | VRK1 | 0.61300915 |
| 103 | SGK3 | 0.61282039 |
| 104 | CSNK1G2 | 0.60039467 |
| 105 | CAMK4 | 0.59117003 |
| 106 | CDC42BPA | 0.58815289 |
| 107 | NME1 | 0.57589423 |
| 108 | FGR | 0.56801874 |
| 109 | CAMKK1 | 0.56672091 |
| 110 | TAF1 | 0.56640665 |
| 111 | ADRBK1 | 0.54983171 |
| 112 | BMPR2 | 0.54929492 |
| 113 | MARK3 | 0.54546675 |
| 114 | FES | 0.53941403 |
| 115 | CSNK1G3 | 0.53085879 |
| 116 | MYLK | 0.52445230 |
| 117 | KSR2 | 0.52408519 |
| 118 | NEK2 | 0.51848524 |
| 119 | OBSCN | 0.51647007 |
| 120 | CSNK1A1 | 0.50745673 |
| 121 | PRKCA | 0.48730345 |
| 122 | DYRK1A | 0.48577140 |
| 123 | RPS6KA5 | 0.48182109 |
| 124 | DDR2 | 0.47697390 |
| 125 | CSNK1A1L | 0.46185599 |
| 126 | PLK1 | 0.45410956 |
| 127 | CAMK2B | 0.45121891 |
| 128 | PRKCQ | 0.43906199 |
| 129 | BCR | 0.42734146 |
| 130 | CDK19 | 0.42623426 |
| 131 | TNK2 | 0.42428697 |
| 132 | PAK4 | 0.42068942 |
| 133 | CDK3 | 0.41948745 |
| 134 | PRKCH | 0.41757501 |
| 135 | PRKACG | 0.41750098 |
| 136 | STK11 | 0.41191033 |
| 137 | CSNK1G1 | 0.40614673 |
| 138 | TYRO3 | 0.40467924 |
| 139 | CAMKK2 | 0.39889624 |
| 140 | PRKG1 | 0.39082594 |
| 141 | MAPK10 | 0.36646171 |
| 142 | MAP2K1 | 0.35740207 |
| 143 | ROCK1 | 0.35476176 |
| 144 | RPS6KA3 | 0.35105002 |
| 145 | ERBB2 | 0.34969879 |
| 146 | MAPK12 | 0.34662058 |
| 147 | FYN | 0.33540057 |
| 148 | PRKACA | 0.33504190 |
| 149 | PDGFRA | 0.32669227 |
| 150 | RIPK1 | 0.32405321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.32671778 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.75393224 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 2.91910653 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.54359867 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.43939841 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.29944900 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.28797705 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.25695359 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.23555212 |
| 10 | Taste transduction_Homo sapiens_hsa04742 | 2.10925299 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.05826560 |
| 12 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.02706271 |
| 13 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.02077169 |
| 14 | Huntingtons disease_Homo sapiens_hsa05016 | 1.99228636 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.97079525 |
| 16 | Long-term potentiation_Homo sapiens_hsa04720 | 1.92736685 |
| 17 | Renin secretion_Homo sapiens_hsa04924 | 1.88821137 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.87062083 |
| 19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.86727392 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 1.83847841 |
| 21 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.80868893 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.75025812 |
| 23 | Axon guidance_Homo sapiens_hsa04360 | 1.74983060 |
| 24 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.73046694 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.69442350 |
| 26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.64868095 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.60612840 |
| 28 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.60242597 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.58231074 |
| 30 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.57524773 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.57215077 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.53225754 |
| 33 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.52574305 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.52266252 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.50915468 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.49614428 |
| 37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.46660062 |
| 38 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.45494828 |
| 39 | Long-term depression_Homo sapiens_hsa04730 | 1.45194607 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.44373010 |
| 41 | RNA polymerase_Homo sapiens_hsa03020 | 1.40477112 |
| 42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.35292735 |
| 43 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.33806266 |
| 44 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.33362809 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.31920134 |
| 46 | Basal transcription factors_Homo sapiens_hsa03022 | 1.30927599 |
| 47 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29539243 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.29495059 |
| 49 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.29250808 |
| 50 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.28668637 |
| 51 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.27459503 |
| 52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.26184984 |
| 53 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.24598082 |
| 54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.23775008 |
| 55 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.20904090 |
| 56 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.19724768 |
| 57 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.18809262 |
| 58 | Melanogenesis_Homo sapiens_hsa04916 | 1.15513620 |
| 59 | Gap junction_Homo sapiens_hsa04540 | 1.14043192 |
| 60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.12428869 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.10443288 |
| 62 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09970017 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09401957 |
| 64 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08598858 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.08313950 |
| 66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.04034181 |
| 67 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.03014359 |
| 68 | RNA degradation_Homo sapiens_hsa03018 | 1.02439356 |
| 69 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.02044329 |
| 70 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.01489243 |
| 71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00537750 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98533953 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.95973053 |
| 74 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.95141174 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.94928620 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93700039 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93366794 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92274491 |
| 79 | Glioma_Homo sapiens_hsa05214 | 0.88978563 |
| 80 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.86848015 |
| 81 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.86298925 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.85889301 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.85045538 |
| 84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84759114 |
| 85 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.84014458 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.83790952 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.83380055 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83316389 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82340872 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.81705058 |
| 91 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79536806 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.79030209 |
| 93 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.77587519 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.77170550 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76558643 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75540530 |
| 97 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.73279166 |
| 98 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.73112721 |
| 99 | Melanoma_Homo sapiens_hsa05218 | 0.73051701 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72934791 |
| 101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.72070326 |
| 102 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71784422 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69886848 |
| 104 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.69823238 |
| 105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.69629249 |
| 106 | Phototransduction_Homo sapiens_hsa04744 | 0.68772183 |
| 107 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67437698 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67110977 |
| 109 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65650016 |
| 110 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64458087 |
| 111 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.63895189 |
| 112 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63884438 |
| 113 | Focal adhesion_Homo sapiens_hsa04510 | 0.63585076 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63402138 |
| 115 | Alzheimers disease_Homo sapiens_hsa05010 | 0.60972342 |
| 116 | Adherens junction_Homo sapiens_hsa04520 | 0.60747547 |
| 117 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.59416038 |
| 118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58491938 |
| 119 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.56314836 |
| 120 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55714170 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51667186 |
| 122 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.51077096 |
| 123 | Peroxisome_Homo sapiens_hsa04146 | 0.50755749 |
| 124 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.50674436 |
| 125 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50329202 |
| 126 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49140499 |
| 127 | Tight junction_Homo sapiens_hsa04530 | 0.48776764 |
| 128 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48771351 |
| 129 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48486387 |
| 130 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48326819 |
| 131 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47588668 |
| 132 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.47512362 |
| 133 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.47375174 |
| 134 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46942951 |
| 135 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45167701 |
| 136 | Purine metabolism_Homo sapiens_hsa00230 | 0.43890171 |
| 137 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43549524 |
| 138 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43545679 |
| 139 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.43287383 |
| 140 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43052470 |
| 141 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41195882 |
| 142 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.40919433 |
| 143 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.39291555 |
| 144 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.38573217 |
| 145 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38435072 |
| 146 | Alcoholism_Homo sapiens_hsa05034 | 0.37837611 |
| 147 | Pathways in cancer_Homo sapiens_hsa05200 | 0.36780532 |
| 148 | Amoebiasis_Homo sapiens_hsa05146 | 0.36340563 |
| 149 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.36263630 |
| 150 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.35700235 |
| 151 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35291108 |
| 152 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35048981 |

